Últimas Notícias
Garanta 50% de desconto 0
Libere dados premium: até 50% de desconto InvestingPro GARANTA JÁ SUA OFERTA
Fecha

Nexpoint Event Driven Fund Class Z (HHCZX)

Criar alerta
Novo!
Criar alerta
Site
  • Como uma notificação de alerta
  • Para usar esse recurso, verifique se você está conectado à sua conta
Aplicativo para celular
  • Para usar esse recurso, verifique se você está conectado à sua conta
  • Verifique se você está conectado com o mesmo perfil de usuário

Condição

Frequência

Uma vez
%

Frequência

Frequência

Método de Entrega

Status

Adicionar/Remover de uma Carteira Adicionar à carteira
Adicionar aos favoritos
Adicionar posição

Posição adicionada com êxito a:

Dê um nome à sua carteira de investimento
 
16,08 +0,02    +0,12%
25/06 - Dados em Atraso. Moeda em USD ( Declaração de Riscos )
  • Classificação da Morningstar:
  • Total de ativos: 36,8M
Tipo:  Fundo
Mercado:  EUA
Emissor:  Highland Funds
Classe de Ativo:  Ações
Highland Long/Short Healthcare Z 16,08 +0,02 +0,12%

HHCZX - Visão Geral

 
Nesta página, você encontrará um perfil aprofundado de Nexpoint Event Driven Fund Class Z. Saiba mais sobre informações de gestão, ativos totais, estratégia de investimento e dados de contato de HHCZX, entre outras informações.
Categoria

Event Driven

Total de ativos

36,8M

Despesas

2,05%

Data de início

39573

Informações de Contato

Endereço 200 Crescent Court, Suite 700
Dallas,TX 75201
United States
Telefone +1 8776651287

Principais Executivos

Nome Título Desde Até
Scott Johnson Portfolio Manager 2022 Agora
Biografia Mr. Johnson is a Managing Director and Portfolio Manager at NexPoint Advisors, L.P. He has over 25 years of investment management experience with extensive experience in private equity, mergers and acquisitions and long/short hedge funds. Prior to joining NexPoint he was the CEO of Enviroklean Product Development which he purchased along with a private equity group. Previously, Mr. Johnson also held positions as President of Trisun Energy Services and was the Portfolio Manager of the Income Fund, L.P., an investment fund focused on making opportunistic investments in public and private debt and equity securities. Prior to managing the Income Fund, he was a Portfolio Manager at Highland Capital Management, L.P. Prior to joining Highland, Mr. Johnson was an Associate at Wellspring Capital Management, a private equity firm focused on control-oriented buyout investments. Mr. Johnson started his career as an Analyst in the Mergers & Acquisitions group at Lehman Brothers. Mr. Johnson received a B.B.A. in Finance with honors from the University of Texas at Austin and an MBA from Harvard Business School.
James D. Dondero President 2018 Agora
Biografia Mr. Dondero is also the co-founder and President of Highland, founder and President of NexPoint Advisors, L.P., Chairman of the board of directors, Chief Executive Officer and member of the investment committee of NXRT, President of NexPoint Capital, Inc., President of NMCT, director for American Banknote Corporation, director for Metro-Goldwyn-Mayer, director for Jernigan Capital, Inc., Chairman of the board of directors for Cornerstone Healthcare, Chairman of the board of directors for CCS Medical, and Chairman of NexBank, an affiliated bank that is majority owned by Mr. Dondero. Mr. Dondero has over 30 years of experience investing in credit and equity markets and has helped pioneer credit asset classes. Prior to founding Highland Capital Management in 1993, Mr. Dondero served as Chief Investment Officer of Protective Life’s GIC subsidiary and helped grow the business between 1989 and 1993. His portfolio management experience includes mortgage-backed securities, investment grade corporates, leveraged bank loans, high-yield bonds, emerging market debt, real estate, derivatives, preferred stocks and common stocks. From 1985 to 1989, he managed in fixed income funds for American Express. Mr. Dondero received a BS in Commerce (Accounting and Finance) from the University of Virginia, and is a Certified Managerial Accountant and a Chartered Financial Analyst.
Eric Fritz - 2021 2022
Biografia Mr. Fritz is an Equity Associate at HCMFA. Prior to joining Highland in July 2013, Mr. Fritz worked as an investment banking analyst for Citigroup Global Markets Inc. (“Citi”). While at Citi, Mr. Fritz advised on and executed capital markets and M&A transactions in the metals & mining, heavy equipment and diversified industrials sectors. Mr. Fritz received a B.B.A. in Finance and Mathematics from the University of Notre Dame.
Nate Burns Managing Director 2019 2021
Biografia Mr. Burns is a Managing Director at HCMLP. Mr. Burns initially joined the Adviser in 2014 as a Director on the absolute return investment team, with responsibility for originating and managing public and private debt and equity investments in the healthcare industry. Prior to joining HCMLP in 2013, he was an Associate at Ripplewood Holdings, a global private equity firm focused on control-oriented buyout, distressed and special situation investments. Prior to joining Ripplewood, he was an Analyst in the Global Technology Mergers & Acquisitions group at Lehman Brothers. Mr. Burns serves on the Board of Directors of Oasis I Limited and Tandem Hospital Partners, LLC. Mr. Burns received a B.S. in Analytical Finance and Economics, summa cum laude, from Wake Forest University and an MBA, with Honors and Distinction, from Columbia Business School. Mr. Burns has also earned the right to use the Chartered Financial Analyst designation.
Andrew Hilgenbrink Managing Director 2018 2019
Biografia Dr. Hilgenbrink is a Managing Director at HCMFA. Prior to his current position he was Director of Investments for an affiliated adviser. Prior to joining HCMFA, Dr. Hilgenbrink was a Director for Cummings Bay’s dedicated healthcare equity funds. Prior to Cummings Bay, he spent four years as a healthcare equity analyst at Jefferies & Company. During his tenure at Jefferies, he covered stocks in a variety of healthcare sectors including specialty pharma, pharmaceutical services, managed care, and healthcare information technology. He has been actively involved in the biotech sector for over seventeen years. This includes pharmaceutical experiences spanning the commercial, research and investment management functions. Dr. Hilgenbrink was a member of the Board of Directors for Molecular Insight Pharmaceuticals prior to its acquisition. Dr. Hilgenbrink holds a Doctorate of Chemistry from Purdue University and a M.B.A. from the Owen Graduate School of Management at Vanderbilt University. He completed his Bachelors of Science degree in Biochemistry from the University of Missouri.
Michael D. Gregory Portfolio Manager 2010 2018
Biografia Michael Gregory is a CIO and Global Head of Highland Alternative Investors at Highland in addition to Managing Director and Head of Healthcare Credit and Healthcare Long/ Short Equity investment strategies. In 2006, he founded Cummings Bay Healthcare Fund, a healthcare hedge fund that is currently in the seventh year of operations and became an affiliate of Highland in 2010. Mr. Gregory also worked as a Partner at Sands Point Capital Management LLC, managing a dedicated healthcare equity hedge fund. Mr. Gregory holds an MBA from the Yale School of Management, having completed a highly specialized joint program in healthcare within the Yale Schools of Medicine, Management and Public Policy. He holds a BS in Economics from the University of Pennsylvania, Wharton School of Business. He is a Fellow of the Royal Society of Medicine, lecturer at Yale University, and frequent guest on CNBC, Fox Business and Morningstar.
James D. Dondero President 2009 2010
Biografia Mr. Dondero is also the co-founder and President of Highland, founder and President of NexPoint Advisors, L.P., Chairman of the board of directors, Chief Executive Officer and member of the investment committee of NXRT, President of NexPoint Capital, Inc., President of NMCT, director for American Banknote Corporation, director for Metro-Goldwyn-Mayer, director for Jernigan Capital, Inc., Chairman of the board of directors for Cornerstone Healthcare, Chairman of the board of directors for CCS Medical, and Chairman of NexBank, an affiliated bank that is majority owned by Mr. Dondero. Mr. Dondero has over 30 years of experience investing in credit and equity markets and has helped pioneer credit asset classes. Prior to founding Highland Capital Management in 1993, Mr. Dondero served as Chief Investment Officer of Protective Life’s GIC subsidiary and helped grow the business between 1989 and 1993. His portfolio management experience includes mortgage-backed securities, investment grade corporates, leveraged bank loans, high-yield bonds, emerging market debt, real estate, derivatives, preferred stocks and common stocks. From 1985 to 1989, he managed in fixed income funds for American Express. Mr. Dondero received a BS in Commerce (Accounting and Finance) from the University of Virginia, and is a Certified Managerial Accountant and a Chartered Financial Analyst.
Brad Means Senior Portfolio Manager 2008 2010
Biografia Means is a Senior Portfolio Manager at Highland Capital Management, L.P. Prior to joining Highland, he was a Managing Director in FTI Consultings Corporate Finance group. From 1998 to 2001, Means was a Director in the PricewaterhouseCoopers Chairmans Office. Prior to this, he worked in the Strategic Change Consulting and the Assurance & Business Advisory groups of Price Waterhouse serving clients. Means holds the Chartered Financial Analyst designation.
Brad Borud Partner, Senior Trader, CIO, Co-Director, Portfolio Manager, Head, Portfoli 2009 2009
Biografia Borud is a Partner, Senior Trader and Chief Investment Officer — Retail Products at Highland Capital Management, L.P. Prior to that, he served as a Senior Trader and Co-Director of Portfolio Management for Highland from 2003 to 2008, as a Portfolio Manager and Team Leader from 2001 to 2003, as a Portfolio Manager from 1998 to 2001, and as a Portfolio Analyst from 1996 to 1998. Prior to joining Highland in November 1996, he worked as a Global Finance Analyst in the Corporate Finance Group from 1995 to 1996.
Nathan Hukill - 2008 2009
Diretrizes para Comentários

Nós o incentivamos a usar os comentários para se engajar com os usuários, compartilhar a sua perspectiva e fazer perguntas a autores e entre si. No entanto, a fim de manter o alto nível do discurso que todos nós valorizamos e esperamos, por favor, mantenha os seguintes critérios em mente:

  • Enriqueça a conversa
  • Mantenha-se focado e na linha. Só poste material relevante ao tema a ser discutido.
  • Seja respeitoso. Mesmo opiniões negativas podem ser enquadradas de forma positiva e diplomática.
  • Use estilo de escrita padrão. Incluir pontuação e letras maiúsculas e minúsculas.
  • NOTA: Spam e/ou mensagens promocionais ou links dentro de um comentário serão removidos.
  • Evite palavrões, calúnias, ataques pessoais ou discriminatórios dirigidos a um autor ou outro usuário.
  • Somente serão permitidos comentários em Português.

Os autores de spam ou abuso serão excluídos do site e proibidos de comentar no futuro, a critério do Investing.com

HHCZX - Comentários

Escreva o que você pensa sobre Nexpoint Event Driven Fund Class Z
 
Tem certeza que deseja excluir esse gráfico?
 
Postar
Postar também no :
 
Substituir o gráfico anexado por um novo gráfico?
1000
A sua permissão para inserir comentários está atualmente suspensa devido a denúncias feitas por usuários. O seu status será analisado por nossos moderadores.
Aguarde um minuto antes de tentar comentar novamente.
Obrigado pelo seu comentário. Por favor, note que todos os comentários estão automaticamente pendentes, em nosso sistema, até que aprovados por nossos moderadores. Por esse motivo, pode demorar algum tempo antes que o mesmo apareça em nosso site.
 
Tem certeza que deseja excluir esse gráfico?
 
Postar
 
Substituir o gráfico anexado por um novo gráfico?
1000
A sua permissão para inserir comentários está atualmente suspensa devido a denúncias feitas por usuários. O seu status será analisado por nossos moderadores.
Aguarde um minuto antes de tentar comentar novamente.
Anexar um gráfico a um comentário
Confirmar bloqueio

Tem certeza de que deseja bloquear %USER_NAME%?

Ao confirmar o bloqueio, você e %USER_NAME% não poderão ver o que cada um de vocês posta no Investing.com.

%USER_NAME% foi adicionado com êxito à sua Lista de bloqueios

Já que acabou de desbloquear esta pessoa, você deve aguardar 48 horas antes de bloqueá-la novamente.

Denunciar esse comentário

Diga-nos o que achou desse comentário

Comentário denunciado

Obrigado!

Seu comentário foi enviado aos moderadores para revisão
Cadastre-se com Google
ou
Cadastre-se com o e-mail